Why AKA isn't just "low glucose plus alcohol" — the NADH/NAD+ mechanism that actually drives it.
Two enzymes, one shared cofactor, and that's the whole story.
| Step | Reaction |
|---|---|
| 1 | Alcohol dehydrogenase (ADH) converts ethanol → acetaldehyde, reducing NAD+ to NADH in the process |
| 2 | Aldehyde dehydrogenase (ALDH) converts acetaldehyde → acetate, again reducing NAD+ to NADH |
| Net | Two sequential NAD+-consuming reactions sharply raise the hepatic NADH/NAD+ ratio |
This is exactly right, and it's the hinge the entire pathophysiology turns on: ethanol metabolism doesn't just burn calories, it specifically depletes the liver's NAD+ pool relative to NADH — and NAD+ is a required cofactor for several key steps elsewhere in intermediary metabolism.
Both downstream effects are correctly attributed to the same upstream cause.
This is the logical payoff of the mechanism, and the post gets the sequencing right.
With the Krebs cycle backed up and unable to fully process incoming acetyl-CoA (itself also increasingly supplied by lipolysis, which is favored under the fasting/starvation state typical of a binge-then-stop drinking pattern with poor oral intake), the liver diverts that excess acetyl-CoA toward ketone body synthesis. The dominant ketone produced in this NADH-excess state is specifically beta-hydroxybutyrate, not acetoacetate — because the high NADH/NAD+ ratio favors the reduction of acetoacetate to beta-hydroxybutyrate. This is an important, correctly-implied detail: standard urine ketone dipsticks primarily detect acetoacetate, not beta-hydroxybutyrate, which is one reason AKA (and DKA in states of severe NADH excess) can under-register on dipstick testing relative to a serum beta-hydroxybutyrate level.
Every mechanistic step in the source post is accurate biochemistry, correctly sequenced: ethanol metabolism raises NADH/NAD+ → that ratio inhibits gluconeogenesis and the Krebs cycle → the liver shifts toward lipolysis and ketogenesis → beta-hydroxybutyrate accumulates, producing the acidotic state. The one clinically useful addition: because this pathway specifically favors beta-hydroxybutyrate over acetoacetate, a standard urine ketone dipstick can under-represent the true ketone burden — a serum beta-hydroxybutyrate level is the more reliable test if AKA is suspected and the dipstick is unimpressive.